Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,522,663,276
-$301,145,376 QoQ
Shares Held
15,023,962
+3.1% QoQ
Ownership
11.2%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. ALNY ranks #2 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,522,663,276 | 15,023,962 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,823,808,652 | 14,579,166 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,323,489,547 | 15,902,149 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,646,037,000 | 16,767,625 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,154,348,428 | 15,806,521 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,133,968,395 | 15,309,860 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,173,367,830 | 13,485,903 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,035,314,965 | 14,672,272 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,955,861,234 | 12,164,038 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,489,717,000 | 9,967,996 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,973,888,059 | 10,312,356 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,997,937,001 | 11,281,406 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,372,825,447 | 12,492,500 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,638,381,664 | 13,170,835 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $3,211,146,522 | 13,512,083 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,592,023,559 | 12,949,758 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,089,264,639 | 14,324,749 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,620,039,648 | 16,045,316 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,042,268,590 | 17,940,020 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,365,902,273 | 17,826,928 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $2,988,930,698 | 17,631,729 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,477,870,520 | 17,549,901 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,091,470,349 | 16,091,947 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $2,397,875,915 | 16,468,928 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,528,923,596 | 17,074,631 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $1,829,257,883 | 16,805,309 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||